Invagen Pharmaceuticals

Rediff.com » News » Invagen Pharmaceuticals

News for Invagen Pharmaceuticals

Business

Glenmark, InvaGen ink deal

Glenmark Pharmaceuticals wholly owned US subsidiary, Glenmark Pharmaceuticals, has made a exclusive marketing tie-up with InvaGen for its Fosinopril Sodium oral tablets (Monopril) in the US market.......

Cipla to acquire two US-based pharma cos for $550 million

Cipla Ltd, India's fourth-largest drugmaker by sales, said on Friday it has agreed to buy two generics businesses in the United States in an all-cash deal worth $550 million to get access to a wide......

Cipla's brilliant plan to make it big in the US

Cipla, though late in changing its strategy for international markets, has in recent years taken an inorganic route for expansion. Cipla’s acquisition of the businesses of InvaGen......

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

This includes seven products which are pending US Food and Drugs Administration approval (abbreviated new drug application) and an approved product spread across diverse dosage forms. Dr......

Earning woes drag markets lower; TCS, HUL lead fall

Markets closed lower for the third straight day with IT giant TCS leading the fall after its Q2 results missed street expectations while lower dollar revenue guidance from Infosys on Monday also......

Invagen Pharmaceuticals

News for Invagen Pharmaceuticals

Glenmark, InvaGen ink deal

Cipla to acquire two US-based pharma cos for $550 million

Cipla's brilliant plan to make it big in the US

Dr Reddy's buys 8 US drugs from Teva, Allergan for $350 million

Earning woes drag markets lower; TCS, HUL lead fall

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS